Value-based health care: issues for pharmaceutical companies
Michael Lampert, Ropes & Gray health care partner, discusses issues facing pharmaceutical companies with the move towards value-based health care models.
Trending Legal Topics Similar Videos
International trade developments
Ama Adams, Ropes & Gray litigation & enforcement partner, discusses the complex array of trade laws and regulations facing companies with international operations.
Enforcement of electronic health records
Joshua Levy, co-chair of Ropes & Gray’s litigation & enforcement practice, addresses an emerging trend in the electronic health records space, where a number of companies are being investigated under the False Claims Act.
Donations to patient assistance charities
Laura Hoey, Ropes & Gray litigation & enforcement partner, examines the increased enforcement of donations from drug manufacturers to patient assistance charities.
Drug pricing initiatives during the Trump presidency
Tom Bulleit, Ropes & Gray health care partner, discusses the Trump Administration’s latest drug pricing initiatives.
Impact of environmental, social and governance agenda on tax
Andrew Howard, Ropes & Gray tax partner, addresses tax coming out of the shadows and becoming part of an environmental, social and governance (ESG) agenda.
SEC activity with fixed income and credit funds
Dan O’Connor, co-leader of Ropes & Gray’s securities & futures enforcement practice, addresses the recent uptick in how the SEC is approaching issues at fixed income and credit funds.